Thermosensitive liposomal doxorubicin plus radiofrequency ablation increased tumor destruction and improved survival in patients with medium and large hepatocellular carcinoma: A randomized, double-blinded, dummy-controlled clinical trial in a single center
Conclusions: RFA with heat target delivery chemotherapy facilitated better tumor coagulation necrosis without additional toxicity. This combined treatment may improve the clinical efficacy of RFA or free doxorubicin and prolong survival in patients with medium to large HCC.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Wei Yang Jung-Chieh Lee Min-Hua Chen Zhong-Yi Zhang Xiu-Mei Bai Shan-Shan Yin Kun Cao Song Wang Wei Wu Kun Yan Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Clinical Trials | CT Scan | Hepatocellular Carcinoma | Liver Cancer | Study | Toxicology | Ultrasound